| [1]尹遵栋.部分地区成人流行性乙型脑炎流行病学特征及疫苗接种的卫生经济学评价[D].北京:中国疾病预防控制中心,2011.
[2]RASHMI K.Prevention,diagnosis,and management of Japanese encephalitis in children[J].Pediatric Health,Medicine and Therapeutics,2014(5):99-110.
[3]郭建花,周吉坤,张世勇,等.石家庄市急性脑炎、脑膜炎病例监测结果分析[J].现代预防医学,2012,39(1):145-147,151.
[4]郭建花,张世勇,齐顺祥,等.石家庄市2001—2010年流行性乙型脑炎流行特征分析[J].中国媒介生物学及控制杂志,2012,23(1):54-56.
GUO J H,ZHANG S Y,QI S X,et al.Epidemiological characteristics and prevention strategy of Japanese encephalitis from 2001 to 2010 in Shijiazhuang[J].Chinese Journal of Vector Biology and Control,2012,23(1):54-56.
[5]ERRA E O,ASKLING H H,YOKSAN S,et al.Cross-protection elicited by primary and booster vaccinations against Japanese encephalitis:a two-year follow-up study[J].Vaccine,2013,32(1):119-123.
[6]WILDER-SMITH A,HALSTEAD S B.Japanese encephalitis:update on vaccines and vaccine recommendations[J].Curr Opin Infect Dis,2010,23(5):426-431.
[7]RANJAN P,GORE M,SELVARAJU S,et al.Changes in acute encephalitis syndrome incidence after introduction of Japanese encephalitis vaccine in a region of India[J].J Infect,2014,69(2):200-202.
[8]WILSON M E.Japanese encephalitis:new vaccines[J].Curr Infect Dis Rep,2009,11(1):37-39.
[9]LIU Y,LIN H,ZHU Q,et al.Safety of Japanese encephalitis live attenuated vaccination in post-marketing surveillance in Guangdong,China,2005—2012[J].Vaccine,2013,32(15):1768-1773.
[10]李艺星,王定明,陈园生,等.流行性乙型脑炎高发地区预防控制策略研究[J].中国疫苗和免疫,2008,14(2):121-123.
LI Y X,WANG D M,CHEN Y S,et al.Prevention and control strategy on Japanese encephalitis in high incidence areas[J].Chinese Journal of Vaccines and Immunization,2008,14(2):121-123.
[11]王萍.淄博市流行性乙型脑炎流行病学特征及直接经济负担研究[D].济南:山东大学,2012.
[12]王轩.河北医大二院住院的中枢神经系统感染的现状分析[D].石家庄:河北医科大学,2012.
[13]王旭霞,李艺星,尹遵栋,等.流行性乙型脑炎流行病学特征及后遗症研究进展[J].中国疫苗和免疫,2008,14(2):176-179.
WANG X X,LI Y X,YIN Z D,et al.Development on epidemiological characteristics and residual sequelae of Japanese encephalitis[J].Chinese Journal of Vaccines and Immunization,2008,14(2):176-179.
[14]HILLS S L,STOLTEY J,MARTNEZ D,et al.A case series of three us adults with Japanese encephalitis,2010—2012[J].J Travel Med,2014,21(5):310-313.
[15]OOI M H,LEWTHWAITE P,LAI B F,et al.The epidemiology,clinical features,and long-term prognosis of Japanese encephalitis in central sarawak,malaysia,1997—2005[J].Clin Infect Dis,2008,47(4):458-468.
[16]CHA G W,CHO J E,JU Y R,et al.Comparison of four serological tests for detecting antibodies to Japanese encephalitis virus after vaccination in children[J].Osong Public Health Res Perspect,2014,5(5):286-291.
[17]刘小波,吴海霞,殷文武,等.2006—2012年全国19省三带喙库蚊监测研究[J].疾病监测,2014,29(4):281-286.
LIU X B,WU H X,YIN W W,et al.Surveillance for Culex tritaeniorhynchus in China,2006—2012[J].Disease Surveillance,2014,29(4):281-286.
[18]李燕婷,朱奕奕,金必红,等.上海市流行性乙型脑炎流行病学分析[J].中国疫苗和免疫,2009,15(6):507-510.
LI Y T,ZHU Y Y,JIN B H,et al.Epidemiological characteristics of Japanese encephalitis in Shanghai[J].Chinese Journal of Vaccines and Immunization,2009,15(6):507-510.
[19]TIAWSIRISUP S,NUCHPRAYOON S.Mosquito distribution and Japanese encephalitis virus infection in the immigration bird(Asian open-billed stork) nested area in Pathum Thani province,central Thailand[J].Parasitol Res,2010,106(4):907-910.
[20]SCHUH A J,WARD M J,BROWN A J,et al.Phylogeography of Japanese encephalitis virus:genotype is associated with climate[J].PLoS Negl Trop Dis,2013,7(8):e2411.
[21]YOSHITO W,NANZABURO O.Relation between the prevalence of culex tritaeniorhnchus and the epidemic of Japanese encephalitis[J].Jap J Trop Med,2011,11(1):16.
[22]LIN H,YANG L,LIU Q,et al.Time series analysis of Japanese encephalitis and weather in Linyi city,China[J].Int J Public Health,2012,57(2):289-296.
[23]CHANGBUNJONG T,WELUWANARAK T,TAOWAN N,et al.Seasonal abundance and potential of Japanese encephalitis virus infection in mosquitoes at the nesting colony of ardeid birds,Thailand[J].Asian Pac J Trop Biomed,2013,3(3):207-210.
[24]KIM N H,LEE W G,SHIN E H,et al.Prediction forecast for culex tritaeniorhynchus populations in Korea[J].Osong Public Health Res Perspect,2014,5(3):131-137.
[25]TOMOHIRO I,EIJI K.Japanese encephalitis:epidemiology,prevention and current status of antiviral drug development[J].Expert Opinion on Orphan Drugs,2014,2(9):923-936. |